FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

The FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC, updating the product’s labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• USTEKINUMAB-TTWE (ustekinumab-ttwe)

Snippet

SUPPL AP for USTEKINUMAB-TTWE (USTEKINUMAB-TTWE)